Investor Overview

Webcast ImageWebcast
Verastem Inc at Jefferies Global Heatlhcare Conference - London (Replay)
11/19/14 at 3:40 a.m. GMT
Verastem Inc at Jefferies Global Heatlhcare Conference - London
Wednesday, November 19, 2014 3:40 a.m. GMT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Verastem, Inc. (NASDAQ: VSTM) is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt.
Stock Quote
VSTM (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.93
Change (%) Stock is Up 0.12 (1.36%)
Volume333,226
Data as of 11/21/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News More >>
DateTitle 
11/21/14Verastem Presents Data at the 2014 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Results from the Phase 1 Dose Escalation Study of VS-6063 in Japanese Patients and New Preclinical Results Support Continued Clinical Development of VS-6063 and VS-5584 in Mesothelioma and Other Cancers BOSTON--(BUSINESS WIRE)--Nov. 21, 2014-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced four poster presentations at the 26th EORTC-NCI-AAC... 
Printer Friendly Version
11/13/14Verastem to Present at the Jefferies 2014 Global Healthcare Conference
BOSTON--(BUSINESS WIRE)--Nov. 13, 2014-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, November 19, 2014 at 3:40 p.m. GMT in London. A live webcast of the presentation can be accessed by visiting the investors section of the Company’s website... 
Printer Friendly Version
11/13/14Verastem to Present Data at the 2014 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
BOSTON--(BUSINESS WIRE)--Nov. 13, 2014-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced scheduled poster presentations at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place November 18 - 21, 2014, in Barcelona, Spain. Verastem is presenting these clinical and preclinical data in support of its pr... 
Printer Friendly Version
11/10/14Verastem to Participate in Panel at the MassBio Patient Advocacy Summit
BOSTON, Mass.--(BUSINESS WIRE)--Nov. 10, 2014-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced today that Robert Forrester, Verastem President and Chief Executive Officer, will participate in a panel titled, “Live & Breathe: Building a Patient-Centered Biotech,” at the MassBio Patient Advocacy Summit on November 10, 2014 at 8:45 am ET at the Genzyme Ce... 
Printer Friendly Version
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Verastem Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.